Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3445)
All Articles published online
|
May 14, 2008 (publication date) through Nov 5, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: |
Robles-Jara C, Robles-Medranda C, Moncayo M, Landivar B, Parrales J. Is a 7-day |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v14/i18/2838.htm |
| Number | Citing Articles |
| 1 |
John E. Lopes. Helicobacter pylori infection: Update on diagnosis and management. Journal of the American Academy of Physician Assistants 2010; 23(7): 20 doi: 10.1097/01720610-201007000-00005
|
| 2 |
Yuhong Yuan, Alex C Ford, Khurram J Khan, Javier P Gisbert, David Forman, Grigorios I Leontiadis, Frances Tse, Xavier Calvet, Carlo Fallone, Lori Fischbach, Giuseppina Oderda, Franco Bazzoli, Paul Moayyedi. Optimum duration of regimens forHelicobacter pylorieradication. Cochrane Database of Systematic Reviews 2013; doi: 10.1002/14651858.CD008337.pub2
|
| 3 |
F. Sierra, J.D. Forero, M. Rey. Tratamiento ideal del Helicobacter pylori: una revisión sistemática. Revista de Gastroenterología de México 2014; 79(1): 28 doi: 10.1016/j.rgmx.2013.03.003
|
| 4 |
F. Sierra, J.D. Forero, M. Rey. Ideal treatment for Helicobacter pylori: A systematic review. Revista de Gastroenterología de México (English Edition) 2014; 79(1): 28 doi: 10.1016/j.rgmxen.2014.05.001
|
| 5 |
H. HIRAISHI, K. HARUMA, H. MIWA, H. GOTO. Clinical trial: irsogladine maleate, a mucosal protective drug, accelerates gastric ulcer healing after treatment for eradication of Helicobacter pylori infection – the results of a multicentre, double‐blind, randomized clinical trial (IMPACT study). Alimentary Pharmacology & Therapeutics 2010; 31(8): 824 doi: 10.1111/j.1365-2036.2010.04250.x
|